Webinars

Upcoming Webinars: 

Title: Innovative Fetal Therapy Approaches

Date: December 16, 2025
Time: 5:30-7:30 pm EST

• In-Utero Therapy with mTOR inhibitors. Speaker: Alireza A. Shamshirsaz, MD
• ETI (Trikefta) for Fetal Cystic Fibrosis. Speaker: Mike Zaretsky, MD
• Fetal Therapies for Lysosomal Storage Diseases. Speaker: Tippi Mackenzie, MD
• Risdiplam for Prenatal Therapy of SMA. Speaker:  Richard S. Finkel, MD

Past Webinars:

Title: Guidelines and Advances of HDFN 

The Guidelines and Advances of HDFN webinar featured expert presentations on the latest strategies for managing hemolytic disease of the fetus and newborn (HDFN). Hiba Mustafa, MD, discussed the use of cell-free DNA testing for determining fetal red blood cell genotype as a non-invasive diagnostic tool, while Kenneth Moise, MD, reviewed the role of IVIG, Nipocalimab, and other emerging therapies in preventing early HDFN. Ahmet Baschat, MD, concluded with practical tips and techniques to optimize intrauterine transfusion procedures, providing attendees with valuable insights and clinical guidance. If you missed any part of the webinar or would like to revisit the content, click the link below to view the recording.

Title: Challenging Case Presentations of Non-Immune Hydrops and the Role of Fetal Therapy - Part Two

As the second installment in the non-immune hydrops topic, this session focused on fetal cardiac conditions and interventions, featuring expert discussions on the diagnosis and treatment of rare tumors such as rhabdomyomas and teratomas. Presenters shared case studies and experiences managing complex fetal conditions including non-immune fetal hydrops, gestational alloimmune liver disease, and sacrococcygeal teratomas. The program also highlighted innovative surgical techniques and debated criteria for fetal interventions, emphasizing the importance of early detection and timely treatment to improve outcomes. If you missed any part of the webinar or would like to revisit the content, click the link below to view the recording.

Title: Challenging Case Presentations of Non-Immune Hydrops and the Role of Fetal Therapy - Part One

As the first installment in this topic, this webinar session focused on challenging case presentations of non-immune hydrops and the role of fetal therapy, with particular emphasis on genetic evaluation and whole genome sequencing in prenatal care. Speakers and panelists reviewed cases involving fetal arrhythmias, anemia, and hydrops, highlighting management strategies such as drug therapies, blood transfusions, and fetal interventions. The discussion concluded with an emphasis on tailoring care to parental goals and the need for further research on long-term outcomes of these treatments. If you missed any part of the webinar or would like to revisit the content, click the link below to view the recording.

Title: Gastroschisis, Clinical and Research 

This NAFTNet-led scientific webinar provided the audience with unconventional and state-of-the-art knowledge and experience from world-renowned experts in the field of prenatal and postnatal management of gastroschisis. Our multidisciplinary expert panel discussed prenatal imaging and predictors of outcomes using both ultrasound and MRI, labor and delivery management including an overview of the gastroschisis "GOOD" trial, postnatal care and surgical management, and innovative fetal surgical intervention approaches covering rationale, eligibility, and surgical techniques.

If you missed any part of the webinar or would like to revisit the content, click the link below to view the recording.